The use of intranasal glucocorticosteroids in the treatment of persistent allergic rhinitis after COVID-19 infection

作者
T. Yu. Vladimirova,A. M. Popova,Mikhail N. Popov
出处
期刊:Медицинский совет [REMEDIUM GROUP LLC]
卷期号: (8): 106-110
标识
DOI:10.21518/2079-701x-2022-16-8-106-110
摘要

Introduction. Modern algorithms for the diagnosis and treatment of allergic rhinitis (AR) recommend a stepwise approach for managing symptoms of the disease. A part of patients with AR have symptoms that indicate to the past COVID-19 followed by significant impairment of the olfactory function. The article places special emphasis on the intranasal glucocorticosteroid option of treatment to manage nasal and general symptoms in persistent AR. The aim of the study is to evaluate the efficacy of mometasone furoate in patients with a confirmed diagnosis of persistent AR, olfactory disorders, and past COVID-19 infection. Materials and methods. A total of 72 patients with persistent AR were included in the randomized controlled prospective study. All patients had a history of olfactory dysfunction with varied severity, which persisted after COVID-19 infection. Results. Measuring the severity of nasal and general symptoms on Day 15 of treatment showed a positive outcome in both groups: the patients of the main group experienced changes, to a greater extent, in nasal congestion, rhinorrhea, olfactory disorders, the patients of the control group generally demonstrated a reduction in nasal congestion, rhinorrhea, itching and sneezing, and improvement of sleep. The final measuring of the severity of complaints on Day 30 of treatment showed that patients of the main group managed to cure the olfactory disorders (0.9 points on the VAS), nasal congestion (0.4 points on the VAS), rhinorrhea and itching (0.2 points on the VAS). Sleep disorders continued to disturb patients in both groups, its improvements in the main group were statistically insignificant. Conclusions. The complaints of nasal congestion, impaired olfactory function and sleep disorders were noted to prevail in patients with persistent form of AR after COVID-19. The followed measuring of the olfactory function using the SST-12 screening test showed that all patients had anosmia. It has been confirmed that the use of mometasone furoate in the treatment of persistent AR in patients with severe olfactory dysfunction after COVID-19 would be appropriate.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
znr发布了新的文献求助10
刚刚
觅与蜜完成签到,获得积分10
刚刚
dans宇完成签到,获得积分10
刚刚
鲸落小小给luo的求助进行了留言
1秒前
科研通AI6.4的应助被他说采纳,获得10
1秒前
搬砖工人完成签到,获得积分10
1秒前
健康的筮完成签到,获得积分10
1秒前
吹笛到天明完成签到,获得积分10
2秒前
哈哈发布了新的文献求助50
2秒前
linn发布了新的文献求助10
2秒前
百柏发布了新的文献求助10
3秒前
Fo发布了新的文献求助10
3秒前
lijiajun完成签到,获得积分10
3秒前
zaq66996完成签到,获得积分10
3秒前
4秒前
春风寒完成签到,获得积分10
4秒前
lyq007完成签到,获得积分10
4秒前
好运连连发布了新的文献求助10
4秒前
dadada发布了新的文献求助10
4秒前
妖精重新煮咖啡完成签到 ,获得积分10
4秒前
默默的香菇完成签到,获得积分10
4秒前
dongdong完成签到 ,获得积分10
4秒前
如是之人完成签到,获得积分10
4秒前
798完成签到,获得积分10
5秒前
悲凉的灵珊完成签到,获得积分10
5秒前
zyy完成签到 ,获得积分10
5秒前
周硕完成签到 ,获得积分10
6秒前
于浩完成签到,获得积分10
6秒前
xin完成签到 ,获得积分10
6秒前
MXL发布了新的文献求助10
7秒前
顾矜的应助被输液袋369采纳,获得10
7秒前
哈哈完成签到,获得积分10
8秒前
YOUNG-M完成签到,获得积分10
8秒前
顺利毕业找好工作完成签到 ,获得积分10
8秒前
邓艳梅完成签到,获得积分10
9秒前
灵巧傥完成签到,获得积分10
9秒前
LLL完成签到,获得积分10
9秒前
wenlon完成签到,获得积分10
9秒前
虚拟龙猫完成签到 ,获得积分10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180339
求助须知:如何正确求助?哪些是违规求助? 9570391
关于积分的说明 21811279
捐赠科研通 7776418
什么是DOI,文献DOI怎么找? 3433277
关于科研通互助平台的介绍 2557483
邀请新用户注册赠送积分活动 2479091